204 related articles for article (PubMed ID: 2160871)
1. Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin).
Invitti C; de Martin M; Brunani A; Piolini M; Cavagnini F
Clin Endocrinol (Oxf); 1990 Mar; 32(3):275-81. PubMed ID: 2160871
[TBL] [Abstract][Full Text] [Related]
2. Lung carcinoid with Cushing's syndrome: control of serum ACTH and cortisol levels using SMS 201-995 (sandostatin).
Hearn PR; Reynolds CL; Johansen K; Woodhouse NJ
Clin Endocrinol (Oxf); 1988 Feb; 28(2):181-5. PubMed ID: 2844445
[TBL] [Abstract][Full Text] [Related]
3. Octreotide exerts different effects in vivo and in vitro in Cushing's disease.
Stalla GK; Brockmeier SJ; Renner U; Newton C; Buchfelder M; Stalla J; Müller OA
Eur J Endocrinol; 1994 Feb; 130(2):125-31. PubMed ID: 8130885
[TBL] [Abstract][Full Text] [Related]
4. The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease.
Lamberts SW; Uitterlinden P; Klijn JM
Acta Endocrinol (Copenh); 1989 Jun; 120(6):760-6. PubMed ID: 2543178
[TBL] [Abstract][Full Text] [Related]
5. Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours.
Cheung NW; Boyages SC
Clin Endocrinol (Oxf); 1992 Apr; 36(4):361-7. PubMed ID: 1424169
[TBL] [Abstract][Full Text] [Related]
6. Failure of somatostatin analogue SMS 201-995 to control Cushing's syndrome due to ectopic release of ACTH from a bronchial carcinoid.
Burrell L; Gray CE; Thomson JA
Scott Med J; 1989 Oct; 34(5):533-4. PubMed ID: 2555918
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for somatostatin and its analogs in Cushing's syndrome?
de Herder WW; Lamberts SW
Metabolism; 1996 Aug; 45(8 Suppl 1):83-5. PubMed ID: 8769391
[TBL] [Abstract][Full Text] [Related]
8. Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism.
Vignati F; Loli P
J Clin Endocrinol Metab; 1996 Aug; 81(8):2885-90. PubMed ID: 8768846
[TBL] [Abstract][Full Text] [Related]
9. [Cushing's syndrome: diagnostic exploration].
Tabarin A; Roger P
Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
[TBL] [Abstract][Full Text] [Related]
10. Potential role for retinoic acid in patients with Cushing's disease.
Pecori Giraldi F; Ambrogio AG; Andrioli M; Sanguin F; Karamouzis I; Corsello SM; Scaroni C; Arvat E; Pontecorvi A; Cavagnini F
J Clin Endocrinol Metab; 2012 Oct; 97(10):3577-83. PubMed ID: 22851491
[TBL] [Abstract][Full Text] [Related]
11. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with SMS 201-995 of Cushing's syndrome caused by ectopic adrenocorticotropin secretion from a metastatic gastrin-secreting pancreatic islet cell carcinoma.
Lamberts SW; Tilanus HW; Klooswijk AI; Bruining HA; van der Lely AJ; de Jong FH
J Clin Endocrinol Metab; 1988 Nov; 67(5):1080-3. PubMed ID: 2846625
[TBL] [Abstract][Full Text] [Related]
13. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.
Reznik Y; Allali-Zerah V; Chayvialle JA; Leroyer R; Leymarie P; Travert G; Lebrethon MC; Budi I; Balliere AM; Mahoudeau J
N Engl J Med; 1992 Oct; 327(14):981-6. PubMed ID: 1325609
[TBL] [Abstract][Full Text] [Related]
14. Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome.
Engelhardt D; Jacob K; Doerr HG
Klin Wochenschr; 1989 Feb; 67(4):241-7. PubMed ID: 2538676
[TBL] [Abstract][Full Text] [Related]
15. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
Findling JW; Kehoe ME; Shaker JL; Raff H
J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
[TBL] [Abstract][Full Text] [Related]
16. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH.
Croughs RJ; Zelissen PM; van Vroonhoven TJ; Hofland LJ; N'Diaye N; Lacroix A; de Herder WW
Clin Endocrinol (Oxf); 2000 Feb; 52(2):235-40. PubMed ID: 10671952
[TBL] [Abstract][Full Text] [Related]
17. Long acting somatostatin treatment of paraneoplastic Cushing's syndrome in a case of Zollinger-Ellison syndrome.
Ruszniewski P; Girard F; Benamouzig R; Mignon M; Bonfils S
Gut; 1988 Jun; 29(6):838-42. PubMed ID: 2898423
[TBL] [Abstract][Full Text] [Related]
18. Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome.
Woodhouse NJ; Dagogo-Jack S; Ahmed M; Judzewitsch R
Am J Med; 1993 Sep; 95(3):305-8. PubMed ID: 8396322
[TBL] [Abstract][Full Text] [Related]
19. Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome.
Starkman MN; Schteingart DE; Schork MA
Psychiatry Res; 1986 Nov; 19(3):177-88. PubMed ID: 3025905
[TBL] [Abstract][Full Text] [Related]
20. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
